Bharat Biotech debunks 'political pressure' claims

Bharat Biotech debunks 'political pressure' claims

Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'

FPJ Web DeskUpdated: Thursday, November 17, 2022, 01:55 PM IST
article-image
Image Source: Wikipedia (Representative)

Bharat Biotech debunks 'political pressure' claims regarding authorisation of Covaxin. It asserts that 'scientific approach was followed.'

A recent report by STAT has emerged about Covaxin and its maker, Bharat Biotech. The investigation suggests that the Hyderabad-based Covaxin developer, Bharat Biotech, had skipped some steps of the Central Drug Standards Control Organization (CDSCO).

According to the report, the Covaxin was rushed due to 'political pressure,' and as a result, it skipped various safeguards in the process before making it available for people.

THIS IS A BREAKING STORY. UPDATES SOON

RECENT STORIES

Precious Metals Prices Slide: Silver Falls 5 Per Cent To ₹2.55 Lakh Per Kg, Gold Drops To ₹1.58...
Precious Metals Prices Slide: Silver Falls 5 Per Cent To ₹2.55 Lakh Per Kg, Gold Drops To ₹1.58...
Ola Electric Delivers Record 34 Per Cent Gross Margin In Q3, Executes Structural Reset To Lower...
Ola Electric Delivers Record 34 Per Cent Gross Margin In Q3, Executes Structural Reset To Lower...
India’s Gem & Jewellery Exports Fall 5.79 Per Cent In January To $2.24 Billion Amid Global Trade...
India’s Gem & Jewellery Exports Fall 5.79 Per Cent In January To $2.24 Billion Amid Global Trade...
Govt Approves Export Of 25 Lakh Tonnes Of Wheat And Additional Sugar Quotas To Stabilise Markets
Govt Approves Export Of 25 Lakh Tonnes Of Wheat And Additional Sugar Quotas To Stabilise Markets
CCL Products Q3 Profit Rises 8% QoQ To ₹141 Crore, Revenue Grows 7% YoY To ₹1,279 Crore
CCL Products Q3 Profit Rises 8% QoQ To ₹141 Crore, Revenue Grows 7% YoY To ₹1,279 Crore